Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Miller, ER, Erlinger, TP, Bohannon, AD, Lin, PH, Svetkey, LP, Sacks, FM, and Appel, LJ. "The effects of dietary patterns on antibodies to oxidized LDL: Results from a randomized clinical trial." Circulation 102, no. 18 (October 31, 2000): 82-82.

Scholars@Duke

Appel, LJ, Charleston, J, Conlin, PR, Erlinger, TP, Harsha, DW, Miller, ER, Moore, TJ, and Svetkey, LP. "The effect of race on circadian patterns of blood pressure: results from the dietary approaches to stop hypertension (DASH) feeding study." Hypertension 36, no. 4 (October 1, 2000): 715-715.

Scholars@Duke

Conlin, PR, Chow, D, Miller, ER, Svetkey, LP, Lin, PH, Harsha, DW, Moore, TJ, Sacks, FM, and Appel, LJ. "The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial." American Journal of Hypertension 13, no. 9 (September 2000): 949-955.

PMID
10981543
Full Text

Svetkey, L. "Genetic determinants of bp response to dash dietary patterns." American Journal of Hypertension 13, no. 6 (June 2000): S76-S76.

Full Text

Klassen, PS, and Svetkey, LP. "Diagnosis and management of renovascular hypertension." Cardiology in Review 8, no. 1 (January 2000): 17-29. (Review)

PMID
11174870
Scholars@Duke

Sharma, , Lewis, EJ, Rohde, R, Bain, RP, Burrows, PK, Edelstein, SL, Pohl, M, Berl, T, Jr, LJ, Blumenthal, S, and al, E. "Erratum: Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin- dependent diabetic patient's (American Journal of Kidney Diseases (1999) 34(818-823))." American Journal of Kidney Diseases 35, no. 3 (2000): 572--null.

Scholars@Duke

Fielding, RA, Violan, MA, Svetkey, L, Abad, LW, Manfredi, TJ, Cosmas, A, and Bean, J. "Effects of prior exercise on eccentric exercise-induced neutrophilia and enzyme release." Medicine and Science in Sports and Exercise 32, no. 2 (2000): 359-364.

Scholars@Duke

Getchell, WS, Svetkey, LP, Appel, LJ, Moore, TJ, Bray, GA, and Obarzanek, E. "Summary of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial." Current Treatment Options in Cardiovascular Medicine 1, no. 4 (December 1999): 295-300.

PMID
11096495
Full Text

Conlin, PR, Bohannon, AD, Miller, ER, Appel, LJ, Erlinger, TP, Hopkins, J, Svetkey, LP, and Moore, TJ. "The DASH diet enhances the blood pressure response to losartan in African American hypertensive patients." Circulation 100, no. 18 (November 2, 1999): 807-807.

Scholars@Duke

Moore, TJ, Vollmer, WM, Appel, LJ, Sacks, FM, Svetkey, LP, Vogt, TM, Conlin, PR, Simons-Morton, DG, Carter-Edwards, L, and Harsha, DW. "Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group." Hypertension (Dallas, Tex. : 1979) 34, no. 3 (September 1999): 472-477.

PMID
10489396
Full Text

Pages